[Beta blockade and diabetes mellitus].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000503:physiopathology*; D005951:Glucose Tolerance Test; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007003:Hypoglycemia / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D007328:Insulin
Betablockad och diabetes mellitus.